Open AccessNormocomplementaemic urticarial vasculitis: effective treatment with omalizumab
Author(s) -
Brito Marianne,
Huebner Gisela,
Murrell DedeeF,
Bullpitt Peter,
Hartmann Karin
Publication year - 2018
Publication title -
clinical and translational allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.979
H-Index - 37
ISSN - 2045-7022
DOI - 10.1186/s13601-018-0222-y
Subject(s) - omalizumab , medicine , vasculitis , dermatology , chronic urticaria , immunology , immunoglobulin e , pathology , antibody , disease
Abstract We report two patients with normocomplementaemic urticarial vasculitis with impressive response to omalizumab. This contrasts recent reports on hypocomplementaemic urticarial vasculitis syndrome, highlighting the need for clinical trials of omalizumab in normocomplementaemic urticarial vasculitis.